Mayo Clinic’s Accelerate Offers AI Startups Access to Expertise, Deidentified EHR Data

The descriptions of a cohort of 18 tech startups that recently joined the Mayo Clinic Platform_Accelerate program offer a glimpse into how entrepreneurs are trying to tackle challenging issues such as early patient risk detection through automation.

Through the program, the companies will participate in an immersive, 30-week program that offers access to expert mentors, technologies and millions of de-identified, longitudinal clinical records to develop and validate AI-driven solutions.

"The future of healthcare depends on clinical insight and technology advancing together," said John Halamka, M.D., Dwight and Dian Diercks President of Mayo Clinic Platform, in a statement. "Accelerate brings entrepreneurs together with Mayo Clinic clinicians and other leading experts to turn bold ideas into practical solutions that can truly improve how care is delivered. It's one more way we're responsibly advancing AI to benefit patients around the world.”

The 18 companies participating in the new cohort include:
• 100ms builds AI agents that automate patient access workflows for specialty practices, including gastroenterology, allergy/immunology and neurology.
• NousLogic Telehealth provides WFH: Wellness from Home, a remote elderly patient monitoring platform that tracks vital signs and real-time medication adherence, including AI-based medication dispensing. 
• MyBackHub is an AI-powered digital health platform that delivers personalized, nonoperative back pain care using AI to triage patients and guide treatment and care coordination.
• Cura AI builds a patient context graph that unifies fragmented patient data into a portable, patient-owned record, enabling conversational AI to support early-risk detection and preventive care.
• SPRYT develops Asa, an AI medical receptionist that empowers patients to book, change and pay for medical appointments via text or instant messaging in their preferred language.
• NeoCure Inc. is developing an AI solution that analyzes bedside vital data to enable timely, specialist-free detection of an eye disease affecting preterm infants.
• Xcoo provides Chrovis, an AI-powered service that supports genomic cancer diagnosis and treatment decisions with clinician-ready insights and patient-friendly reports.
• YOBO Health offers a care coordination platform designed to help prevent hospital readmissions among patients with cardio-renal-metabolic conditions.
• Canary Applied Intelligence delivers a patient-centric AI platform for cardio-renal care that identifies high-risk patients early and enables proactive, data-driven interventions across the care journey.
• Curenetics is a U.K.-based AI-driven health technology company that predicts individual patient response to cancer immunotherapy by integrating clinical, genomic and imaging data.
• Bluevia Health is an applied AI platform that analyzes multimodal clinical data to detect postoperative deterioration earlier, helping health systems identify complications sooner and improve surgical outcomes.
• Precision Imaging Inc. is a Tokyo-based medtech startup specializing in AI-powered intraoperative navigation that uses computer vision to deliver cost-effective, high-precision guidance for orthopedic surgery, starting with total hip arthroplasty.
• Avedian provides the Compass Decision Support platform, delivering operational insights that help health systems improve efficiency, performance and capacity planning.
• Hoopcare reduces surgical risk and improves operating room efficiency by automating preoperative evaluation and predicting postoperative complications with AI.
• Hera is an AI-powered male fertility platform that combines testing with predictive analytics to deliver personalized sperm health insights for patients, clinics and fertility programs.
• EW2Health is a digital health platform that uses predictive behavioral analytics to support GLP-1–based obesity care by forecasting weight trends and enabling proactive, personalized interventions to improve adherence and long-term metabolic health.
• Ecotone AI applies frontier AI and full-genome analysis to uncover disease-driving genetic mechanisms and accelerate precision therapies for rare diseases at scale.
• OneMedic is a Vietnam-based health tech company using an AI-driven ecosystem to enable early detection and proactive management of chronic disease through integrated, patient-centered care in a primary care setting.

"The innovation we're seeing in this February cohort is a testament to the accelerating pace of AI in medicine," said Jamie Sundsbak, director of the Accelerate program, in a statement. "We are proud to support these 18 companies as they transition from revolutionary concepts to scalable solutions that can help define the next decade of healthcare."